International Law Archives - Page 26 of 41 - Customs & International Trade Law Firm

U.S. Expands Trade War to EU

After winning the largest arbitration award (7.5 billion) in World Trade Organization (WTO) history in its dispute with the European Union (EU) over illegal subsidies to Airbus, the United States (US) will begin applying WTO-approved tariffs on certain EU goods beginning October 18. Although USTR has the authority to apply a 100 percent tariff on affected products, at this time the tariff increases will be limited to 10% on large civil aircrafts and 25% on agricultural and other products. The U.S. has the authority to increase the tariffs at any time, or change the products affected.

[…]

By Jennifer Diaz|2022-07-07T13:47:56-04:00October 4, 2019|Customs Broker, Customs Expert, Enforcement, Import, International Business, International Law, International Trade, U.S. Customs and Border Protection (CBP)|0 Comments

New FTC Warning Letters Issued to Companies Selling CBD Products

The United States Federal Trade Commission (FTC) issued a press release confirming is sent three warning letters to companies that sell oils, tinctures, capsules, “gummies,” and creams containing cannabidiol (CBD), a chemical compound derived from the cannabis plant. While the warning letters are not made publicly available, the FTC advised the warning letters were sent because the companies were advertising their CBD products could treat or cure serious diseases and health conditions, in violation of both the FTC Act (as well as U.S. Food and Drug Administration (FDA)) laws and regulations.

[…]

By Jennifer Diaz|2022-07-07T13:46:03-04:00September 24, 2019|CBD, Export, FDA Issues, Import Alert, International Law, International Trade, U.S. Customs and Border Protection (CBP), U.S. Federal Trade Commission (FTC)|0 Comments

Here are the Major Changes FDA is Proposing to Make to the Sunscreen Rule!

On February 26 2019, the United States Food and Drug Administration (FDA) proposed a rule that would alter the regulations associated with the manufacturing and selling of sunscreen, as well as other sun-care related products. Since the closing of the comment period on May 28^th, 2019, FDA has received over one thousand comments from industry players voicing their concern over various aspects of the proposed measures.

The proposed rule was issued as part of the regulatory proceeding to put into effect a final monograph for nonprescription, OTC sunscreen drug products under the OTC Drug Review. An OTC monograph establishes conditions under which certain OTC drugs may be marketed without approved new drug applications because they are generally recognized as safe and effective (GRASE) and not misbranded. The proposed rule classifies active ingredients and other conditions as:

[…]

By Jennifer Diaz|2022-07-07T13:45:15-04:00September 17, 2019|FDA Issues, International Law, International Trade, International Travel|0 Comments

India removed from GSP, potential problems permeate

After the Trump Administration officially revoked India’s participation in the Generalized System of Preference (GSP) on June 5, 2019, India announced that it intends to implement tariffs on roughly 30 HTS-listed items. The items-which include many agricultural goods, such as almonds and apples- would be subjected to 70% duties upon entry.

[…]

TOP 5 Strategies to Mitigate the Impact of Tariffs

Many importers, exporters, and international businesses alike may be unaware that avenues exist to ensure that their products remain unabated by protectionist trade policies (think China tariffs).

This blog provides an easy reference overview of five (5) proven and legitimate options for duty-saving opportunities.

We recommend U.S. importers, exporters, and manufacturers to consider these five (5) options as they apply to all products from virtually any country subjected to a tariff, including Section 201 tariffs for solar systems, Section 232 tariffs for aluminum and steel, and the infamous Section 301 Tariffs in place for Chinese originating goods and violations of trade agreements, as well as acts, policies or practices that are unjustifiable, unreasonable, or discriminatory and that burden or restrict U.S. commerce.

[…]

By Jennifer Diaz|2022-07-07T13:41:03-04:00August 26, 2019|AD/CVD, China, China Trade War, Customs Broker, Customs Expert, Expert, Export, Free Trade Agreement, HTSUS, Import, International Business, International Law, International Trade, Pre-compliance, Supply Chain, U.S Department of Homeland Security (DHS), U.S. Customs and Border Protection (CBP), U.S. Department of State (DOS)|0 Comments

Previous 252627 Next